相关实验视频
Updated: Jul 24, 2025

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
TCRward个性化的移植疗法
Ashima Chadha1, Jonathan S Maltzman1,2
1Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
单细胞RNA (scRNA) 和T细胞受体 (TCR) 测序的脏活检显示,在急性细胞排斥期间,T细胞克隆性有限. 观察到多种T细胞表型,表明移植患者的复杂免疫反应.
科学领域:
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 基因组学就是基因组学.
背景情况:
- 急性细胞排斥 (ACR) 是移植失败的主要原因之一.
- 了解ACR中的T细胞谱系对于开发向疗法至关重要.
研究的目的:
- 通过单细胞测序来表征ACR患者脏活检中的T细胞群和克隆性.
- 为了研究在排斥过程中入脏的T细胞的表型多样性.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 和T细胞受体测序 (TCR-seq) 在ACR患者的脏活检样本上进行.
- 生物信息分析用于识别T细胞子集,评估克隆性和分析基因表达特征.
主要成果:
- 在ACR脏活检中观察到有限的T细胞克隆性,表明多克隆的T细胞反应.
- 鉴定出了多种T细胞表型,包括效应细胞和调节性T细胞.
- 特定的T细胞子集与排斥的严重程度有关.
结论:
- 在ACR中,T细胞反应的特征是有限的克隆性,但具有多样化的表型.
- 这些发现凸显了脏异位移植排斥中免疫机制的复杂性.
- 对特定T细胞子集的进一步研究可能会导致新的治疗策略来预防或治疗ACR.
更多相关视频
16:26Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013
相关概念视频
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cell-mediated Immune Responses
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Targeted Cancer Therapies
There are several types of targeted therapies against...